We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Global Payments (GPN) Q1 Earnings Beat, Ups 2018 View
Read MoreHide Full Article
Have you been eager to see how Global Payments Inc. (GPN - Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this company’s earnings release this morning.
An Earnings Beat
Global Payments came out with adjusted earnings per share of $1.13 per share, beating the Zacks Consensus Estimate of $1.09 per share and grew 33% year over year.
Global payments posted revenues of $722.7 million which missed the Zacks Consensus Estimate of $918 million and declined 10.1% year over year.
Key Stats to Note
Total operating expense of $638.8 million decreased 21.6% year over year led by 44.6% drop in cost of service.
Adjusted operating margin improved 140 basis points to 30.4%.
Long term debt as of Mar 31, 2018 was $4.2 billion down from $4.6 billion at 2017 end.
Guidance Raised
For 2018 the company expects adjusted earnings to a range of $5.00-$5.20 from $4.95 to $5.15 per share guided earlier.
Adjusted net revenues are estimated between $3.9 billion and 3.975 billion from $3.88 billion to $3.97 billion expected previously.
Adjusted operating margin for 2018 is projected to expand 120 basis points.
What Zacks Rank Says
Global Payments carries a Zacks Rank #4 (Sell). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
Check back later for our full write up on this Global Payments earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Global Payments (GPN) Q1 Earnings Beat, Ups 2018 View
Have you been eager to see how Global Payments Inc. (GPN - Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this company’s earnings release this morning.
An Earnings Beat
Global Payments came out with adjusted earnings per share of $1.13 per share, beating the Zacks Consensus Estimate of $1.09 per share and grew 33% year over year.
Global Payments Inc. Price and EPS Surprise
Global Payments Inc. Price and EPS Surprise | Global Payments Inc. Quote
Revenue Miss
Global payments posted revenues of $722.7 million which missed the Zacks Consensus Estimate of $918 million and declined 10.1% year over year.
Key Stats to Note
Total operating expense of $638.8 million decreased 21.6% year over year led by 44.6% drop in cost of service.
Adjusted operating margin improved 140 basis points to 30.4%.
Long term debt as of Mar 31, 2018 was $4.2 billion down from $4.6 billion at 2017 end.
Guidance Raised
For 2018 the company expects adjusted earnings to a range of $5.00-$5.20 from $4.95 to $5.15 per share guided earlier.
Adjusted net revenues are estimated between $3.9 billion and 3.975 billion from $3.88 billion to $3.97 billion expected previously.
Adjusted operating margin for 2018 is projected to expand 120 basis points.
What Zacks Rank Says
Global Payments carries a Zacks Rank #4 (Sell). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on this Global Payments earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>